Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of June 2025. The report specifically details a transaction in own shares executed under the Company's share buyback programme announced on March 28, 2025.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on share repurchase activity.
- Shares Purchased: 966,880 ordinary shares
- Purchase Date: June 13, 2025
- Highest Price Paid: 399.60 pence per share
- Lowest Price Paid: 394.60 pence per share
- Volume Weighted Average Price: 396.97 pence per share
- Treasury Shares Held: 4,080,205
- Shares with Voting Rights: 8,992,482,913
Material Changes
Following the settlement of the June 13 transaction, the Company's registered share capital remains 8,996,563,118 ordinary shares of £0.01 each. The number of shares held as treasury shares increased to 4,080,205, resulting in a reduction of the total number of ordinary shares with voting rights to 8,992,482,913.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on operational outlook, or discussion of risks and contingencies. It is a routine disclosure of a share buyback transaction in compliance with the Market Abuse Regulation (Article 5(1)(b) of Regulation (EU) No 596/2014).
Key Facts for Investor Verification
- Verify the total number of shares purchased to date under the Buyback Programme announced on March 28, 2025.
- Confirm the current number of treasury shares held (4,080,205) against the latest capital structure.
- Review the full breakdown of individual trades available via the London Stock Exchange link provided in the filing.
- Check the updated share count with voting rights (8,992,482,913) for compliance with FCA Disclosure Guidance and Transparency Rules.